Uso del sevelamer en la enfermedad renal crónica. Más allá del control del fósforo

Rodríguez-Osorio, Laura; Pazmiño Zambrano, Diana; Gracia-Iguacel, Carolina; Rojas-Rivera, Jorge; Ortiz, Alberto; Egido, Jesus; González Parra, Emilio.
Nefrología (Madr.) ; 35(2): 207-217, mar.-abr. 2015. ilus, tab
Artículo en Español | IBECS (España) | ID: ibc-139288

Documentos relacionados

  1. Family-centered empowerment approach to optimize phosphate management among hemodialysis patients: an experimental study.
  2. 'Phos'tering a Clear Message: The Evolution of Dietary Phosphorus Management in Chronic Kidney Disease.
  3. The challenge of controlling phosphorus in chronic kidney disease.
  4. Con: Phosphate binders in chronic kidney disease.
  5. Survival advantage of lanthanum carbonate for hemodialysis patients with uncontrolled hyperphosphatemia.
  6. Systematic Review and Meta-Analyses of the Effects of Phosphate-Lowering Agents in Nondialysis CKD.
  7. How to evaluate phosphate control in patients on dialysis.
  8. Prevalence of Phosphorus-Based Additives in the Australian Food Supply: A Challenge for Dietary Education?
  9. Implementation and effectiveness of an intensive education program on phosphate control among hemodialysis patients: a non-randomized, single-arm, single-center trial.
  10. Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update.